Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.70 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | TGM2 | P21980 | 1/20 | 0.52 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.51 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.51 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.49 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24486768 | 0.92 | HTT (0.63) | LMNASMN1; SMN2HTTL3MBTL1MAPT | |
| SCHEMBL29592964 | 0.87 | LMNA (0.68) | LMNASMN1; SMN2HTTL3MBTL1MAPT | |
| SCHEMBL8189834 | 0.86 | LMNA (0.63) | LMNASMN1; SMN2HTTL3MBTL1MAPT | |
| SCHEMBL9932079 | 0.85 | LMNA (0.62) | LMNASMN1; SMN2HTTL3MBTL1MAPT | |
| SCHEMBL4312519 | 0.85 | LMNA (0.56) | LMNASMN1; SMN2HTTL3MBTL1TGM2 | |
| SCHEMBL21171855 | 0.84 | SMN1; SMN2 (0.49) | LMNASMN1; SMN2HTTL3MBTL1MAPT | |
| SCHEMBL21533723 | 0.84 | LMNA (0.50) | LMNASMN1; SMN2HTTL3MBTL1MAPT | |
| SCHEMBL9932446 | 0.83 | LMNA (0.63) | LMNASMN1; SMN2HTTL3MBTL1MAPT | |
| SCHEMBL5063193 | 0.83 | LMNA (0.77) | LMNASMN1; SMN2HTTL3MBTL1MAPT | |
| SCHEMBL7372302 | 0.83 | SMN1; SMN2 (1.00) | LMNASMN1; SMN2HTTL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114591361-B | Preparation method of (R) -glycerophosphatidylethanolamine | 苏州昊帆生物股份有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-114591361-B | Preparation method of (R) -glycerophosphatidylethanolamine | 苏州昊帆生物股份有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-114591361-B | Preparation method of (R) -glycerophosphatidylethanolamine | 苏州昊帆生物股份有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-20220412963-A1 | FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES THROUGH REDUCTIVE AMINATION FOR ENHANCED MS SIGNALS | WATERS TECHNOLOGIES CORPORATION | 2022-12-29 | — | — | US | disclosed |
| US-11353461-B2 | Methods of enhancing MS detection of tagged glycans | WATERS TECHNOLOGIES CORPORATION (US) | 2022-06-07 | — | — | US | disclosed |
| US-11061023-B2 | Fluorescence tagging of glycans and other biomolecules through reductive amination for enhanced MS signals | WATERS TECHNOLOGIES CORPORATION (US) | 2021-07-13 | — | — | US | disclosed |
| US-20190331669-A1 | FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES THROUGH REDUCTIVE AMINATION FOR ENHANCED MS SIGNALS | WATERS TECHNOLOGIES CORPORATION (US) | 2019-10-31 | — | — | US | disclosed |
| US-20190219587-A1 | METHODS OF ENHANCING MS DETECTION OF TAGGED GLYCANS | WATERS TECHNOLOGIES CORPORATION | 2019-07-18 | — | — | US | disclosed |
| US-20070264667-A1 | Method and system for assaying transferase activity | GELLIBOLIAN ROBERT | 2007-11-15 | — | — | US | disclosed |
| WO-2005024380-A9 | METHOD AND SYSTEM FOR ASSAYING TRANSFERASE ACTIVITY | GELLIBOLIAN ROBERT (US) | 2005-07-07 | — | — | WO | disclosed |
| WO-2005024380-A2 | METHOD AND SYSTEM FOR ASSAYING TRANSFERASE ACTIVITY | GELLIBOLIAN ROBERT (US) | 2005-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190331669-A1 | FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES THROUGH REDUCTIVE AMINATION FOR ENHANCED MS SIGNALS | FUT5, FUT6, OGT | LMNA 1541/4885SMN1; SMN2 4264/4885HTT 1546/4885 |
| US-20220412963-A1 | FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES THROUGH REDUCTIVE AMINATION FOR ENHANCED MS SIGNALS | FUT5, FUT6, OGT | LMNA 1541/4885SMN1; SMN2 4264/4885HTT 1546/4885 |
| US-11061023-B2 | Fluorescence tagging of glycans and other biomolecules through reductive amination for enhanced MS signals | FUT5, FUT6, OGT | LMNA 1541/4885SMN1; SMN2 4264/4885HTT 1546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.